Checkpoint Therapeutics, Inc. (CKPT)

Checkpoint Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	4.7	4.93	12.07	54.74	40.77	26.08
Cash & Short-Term Investments	4.7	4.93	12.07	54.74	40.77	26.08
Cash Growth	165.41%	-59.16%	-77.95%	34.25%	56.35%	18.56%
Receivables	-	-	0.07	0.02	0.02	0.03
Prepaid Expenses	0.48	0.45	1.15	0.98	1.8	0.86
Total Current Assets	5.18	5.38	13.29	55.73	42.6	26.97
Total Assets	5.18	5.38	13.29	55.73	42.6	26.97
Accounts Payable	7.89	6.57	11.54	16.14	3.44	3.08
Accrued Expenses	9.53	11.14	9.79	9.61	3.39	4.77
Other Current Liabilities	0.35	0.71	11.45	0.23	0.39	0.27
Total Current Liabilities	17.77	18.43	32.77	25.98	7.22	8.12
Total Liabilities	17.77	18.43	32.77	25.98	7.22	8.12
Common Stock	0.01	0	0	0	0.01	0.01
Additional Paid-In Capital	329.08	297.86	241.12	223.01	173.95	136.44
Retained Earnings	-341.67	-314.33	-262.49	-199.86	-143.19	-120.11
Comprehensive Income & Other	-	3.42	1.89	6.6	4.62	2.51
Shareholders' Equity	-12.59	-13.05	-19.48	29.75	35.38	18.85
Total Liabilities & Equity	5.18	5.38	13.29	55.73	42.6	26.97
Net Cash (Debt)	4.7	4.93	12.07	54.74	40.77	26.08
Net Cash Growth	165.41%	-59.16%	-77.95%	34.25%	56.35%	18.56%
Net Cash Per Share	0.10	0.18	1.17	6.47	7.30	7.39
Filing Date Shares Outstanding	48.83	35.69	12.95	9.06	7.52	5.5
Total Common Shares Outstanding	45.8	27.74	10.29	8.46	6.94	5.4
Working Capital	-12.59	-13.05	-19.48	29.75	35.38	18.85
Book Value Per Share	-0.27	-0.47	-1.89	3.52	5.10	3.49
Tangible Book Value	-12.59	-13.05	-19.48	29.75	35.38	18.85
Tangible Book Value Per Share	-0.27	-0.47	-1.89	3.52	5.10	3.49

Source: S&P Capital IQ. Standard template. Financial Sources.